Aug 25 (Reuters) - Regis Healthcare Ltd (REG) :
- FY 2017 EBITDA is anticipated to be in excess of 15% more than normalised FY
2016
- The company is expected to have higher depreciation charge than in FY 2016
- Says total capex spend is anticipated to be in the order of $160M in FY 2017
- * (( )) (([email protected]))
News: REG Regis Healthcare says FY 2017 EBITDA anticipated to be in excess of 15%
Add REG (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.53 |
Change
0.050(0.77%) |
Mkt cap ! $1.755B | |||
| Open | High | Low | Value | Volume |
| $6.62 | $6.64 | $6.45 | $255.8K | 39.09K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 627 | $6.53 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.54 | 1084 | 4 |
View Market Depth
| Last trade - 10.19am 26/11/2024 (20 minute delay) ? |
| REG (ASX) Chart |
